- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Early Stage Prostate Cancer in Canada
Total 815 results
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Janssen Research & Development, LLCCompletedMetastatic Prostate CancerUnited States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
-
Centre hospitalier de l'Université de Montréal...McMaster University; Queen's University; London Health Sciences Centre; Canadian... and other collaboratorsActive, not recruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerCanada, United States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Netherlands, Hungary, Czech Republic, Germany, Mexico, Romania, Russian Federation, Ukraine, Canada, Puerto Rico, United Kingdom
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)Completed
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Southwest Oncology GroupCompleted
-
Lawson Health Research InstituteRecruitingNon-small Cell Lung Cancer Stage IB (Resectable) | Non-small Cell Lung Cancer Stage II (Resectable) | Non-small Cell Lung Cancer Stage ⅢA (Resectable)Canada
-
NCIC Clinical Trials GroupS*BIOCompleted
-
Eisai Inc.CompletedProstate CancerFrance, United States, Romania, Canada, Peru, Brazil, Russian Federation, Chile, Croatia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Active Biotech ABCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
NCIC Clinical Trials GroupCompletedProstate CancerUnited States, Canada
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
NovaceaAventis PharmaceuticalsUnknownProstate CancerCanada, United States
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical CancerCanada
-
University Health Network, TorontoActive, not recruiting
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada
-
DendreonCompletedProstate CancerUnited States, Canada
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
ESSA PharmaceuticalsRecruitingProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Institute... and other collaboratorsTerminated
-
National Cancer Institute (NCI)TerminatedStage I Uterine Corpus Cancer AJCC v7 | Stage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Cervical Carcinoma | Stage IB2 Cervical Cancer AJCC v6 and v7 | Stage II Cervical Cancer AJCC v7 | Stage II Vaginal Cancer AJCC v6 and v7 and other conditionsUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerCanada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerSpain, Netherlands, Belgium, Italy, France, Germany
-
Cell GenesysTerminatedProstate CancerUnited States, France, Belgium, Canada, United Kingdom, Sweden, Netherlands, Germany
-
NCIC Clinical Trials GroupOncothyreon Canada Inc.Completed
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Centre hospitalier de l'Université de Montréal...Active, not recruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Janssen Research & Development, LLCCompletedProstate CancerUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Netherlands, Greece, Sweden
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted